Dr. Jonathan Harris Robbins, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Rd, Suite 3b, Leominster, MA 01453 Phone: 978-534-3179 Fax: 978-840-3161 |
Dr. Ellen M Gallant, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 60 Hospital Rd, Leominster, MA 01453 Phone: 978-466-2052 |
Mark Joseph O'connor Jr., M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Rd Ste 3a-b, Leominster, MA 01453 Phone: 978-534-3179 Fax: 978-840-3161 |
Maureen A Maher, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Rd, 3b, Cardiology Internists, Leominster, MA 01453 Phone: 978-534-3179 Fax: 978-840-3161 |
Dr. Nicholas Michael Mercadante, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 100 Hospital Rd, Suite 3b, Professional Building, Leominster, MA 01453 Phone: 978-534-3179 Fax: 978-840-3161 |
News Archive
StemCells, Inc. announced today that it has entered into an agreement to raise approximately $12.5 million in gross proceeds through the sale of approximately 10 million shares of its common stock to selected institutional investors at a price of $1.25 per share. The investors will also receive warrants to purchase approximately four million shares of common stock at an exercise price of $1.50 per share.
Today's health policy headlines include previews of the expected release of a national strategy to curb the AIDS epidemic and reviews of a White House official's Sunday talk show defense of the Berwick nomination.
In a study of healthy postmenopausal women, reproductive life events related to sex hormones, including earlier age at menarche, later age at last pregnancy, length of reproductive period, and use of oral contraceptives were positively related to aspects of cognition in later life.
A protein found in the virulent avian influenza virus strain called H5N1 forms tiny tubules in which it "hides" the pieces of double-stranded RNA formed during viral infection, which otherwise would prompt an antiviral immune response from infected cells, said Baylor College of Medicine researchers in an online report in the journal Nature.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
› Verified 2 days ago